Josh Mitteldorf
Research Subjects
Research Interests
Josh Mitteldorf has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- John F. McGowan2 shared publications
- John William Pepper
National Cancer Institute
2 shared publications - Tam Hunt
Univ. of California, Santa Barbara, USA
2 shared publications C. Goodnight
University of Vermont
1 shared publicationCharles Goodnight
Dept of Ecology and Evolutionary Biology, Univ. of Arizona, Tucson, AZ 85720, USA
1 shared publicationDonald O. Landon
1 shared publication
Latest Publications
- Open Access
- 1 August 2026
- Published by Qeios Ltd
Review of: "The Future of Longevity Medicine: Repairing the Parts or Preserving the Whole?Holmes’ Carriage as a Metaphor for Two Fundamentally Different Models of Aging"
Caveat: This essay takes the perspective that aging is something that happens to the body, whereas I have devoted two books and many articles to the thesis that aging is something the body does to itself. Therefore, I am less interested in the primar...
- 1 August 2026
- Published by Qeios Ltd
Open AccessReview of: "The Future of Longevity Medicine: Repairing the Parts or Preserving the Whole?Holmes’ Carriage as a Metaphor for Two Fundamentally Different Models of Aging"
Caveat: This essay takes the perspective that aging is something that happens to the body, whereas I have devoted two books and many articles to the thesis that aging is something the body does to itself. Therefore, I am less interested in the primar...
- Open Access
- 5 May 2025
- Published by Impact Journals, LLC in Aging
- Vol. 17 (5) , 1082-1090
Methylation clocks for evaluation of anti-aging interventions
Methylation clocks have found their way into the community of aging research as a way to test anti-aging interventions without having to wait for mortality statistics. But methylation is a primary means of epigenetic control, and presumably has evolved under strong selection. Hence, if methylation patterns change consistently at late ages it must mean one of two things. Either (1) the body is evolved to destroy itself (with inflammation, autoimmunity, etc.), and the observed methylation changes are a means to this end; or (2) the body detects accumulated damage, and is ramping up repair mechanisms in a campaign to rescue itself. My thesis herein is that both Type 1 and Type 2 changes are occurring, but that only Type 1 changes are useful in constructing methylation clocks to evaluate anti-aging interventions. This is because a therapy that sets back Type 1 changes to an earlier age state has stopped the body from destroying itself; but a therapy that sets back Type 2 changes has stopped the body from repairing itself. Thus, a major challenge before the community of epigenetic clock developers is to distinguish Type 2 from Type 1. The existence of Type 1 epigenetic changes is in conflict with conventional Darwinian thinking, and this has prompted some researchers to explore the possibility that Type 1 changes might be a form of stochastic epigenetic drift. I argue herein that what seems like directed epigenetic change really is directed epigenetic change. Of five recent articles on “stochastic methylation clocks,” only one (from the Conboy lab) is based on truly stochastic changes. Using the Conboy methodology and a methylation database, I construct a measure of true methylation drift, and show that its correlation with age is too low to be useful.
- 5 May 2025
- Published by Impact Journals, LLC in Aging
- Vol. 17 (5) , 1082-1090
Open AccessMethylation clocks for evaluation of anti-aging interventions
Methylation clocks have found their way into the community of aging research as a way to test anti-aging interventions without having to wait for mortality statistics. But methylation is a primary means of epigenetic control, and presumably has evolved under strong selection. Hence, if methylation patterns change consistently at late ages it must mean one of two things. Either (1) the body is evolved to destroy itself (with inflammation, autoimmunity, etc.), and the observed methylation changes are a means to this end; or (2) the body detects accumulated damage, and is ramping up repair mechanisms in a campaign to rescue itself. My thesis herein is that both Type 1 and Type 2 changes are occurring, but that only Type 1 changes are useful in constructing methylation clocks to evaluate anti-aging interventions. This is because a therapy that sets back Type 1 changes to an earlier age state has stopped the body from destroying itself; but a therapy that sets back Type 2 changes has stopped the body from repairing itself. Thus, a major challenge before the community of epigenetic clock developers is to distinguish Type 2 from Type 1. The existence of Type 1 epigenetic changes is in conflict with conventional Darwinian thinking, and this has prompted some researchers to explore the possibility that Type 1 changes might be a form of stochastic epigenetic drift. I argue herein that what seems like directed epigenetic change really is directed epigenetic change. Of five recent articles on “stochastic methylation clocks,” only one (from the Conboy lab) is based on truly stochastic changes. Using the Conboy methodology and a methylation database, I construct a measure of true methylation drift, and show that its correlation with age is too low to be useful.
- Open Access
- 13 December 2024
- Published by Wiley
Sex and Cellular Senescence in Ciliates
Mixing and sharing of genes is essential for population diversity, which contributes to the resilience and, ultimately, the survival of animal and plant communities. However, sharing of genes is antithetical to individual fitness; hence gene mixing is threatened with extinction if selection rewards selfish (clonal) reproduction. To address this dilemma, mechanisms have evolved to enforce a mandate for gene sharing. In most metazoa, the functions of sex and reproduction are tightly entwined, presumably for the purpose of compelling the sharing of genes. In protists, the functions of sex (conjugation) and reproduction (amitosis) are separate. The mandate for gene sharing is enforced, instead, by a form of cellular senescence. Ciliates can reproduce clonally a few hundred times before they senesce and die. Conjugation resets their biological clock, restarting the cycle of clonal reproduction. The question how reproduction in metazoa came to be linked to sex has been explored in the past, but a fully satisfying account in terms of evolutionary ecology is lacking. The question how senescence in protozoa came to be linked to sex has not been addressed, and is the topic of the current study. I present herein two numerical simulations (IBMs) for the evolution of cellular senescence in ciliates. The results shed light not only on the evolution of senescence in higher life forms, but on more general questions concerning the plausibility of group selection.
- 13 December 2024
- Published by Wiley
Open AccessSex and Cellular Senescence in Ciliates
Mixing and sharing of genes is essential for population diversity, which contributes to the resilience and, ultimately, the survival of animal and plant communities. However, sharing of genes is antithetical to individual fitness; hence gene mixing is threatened with extinction if selection rewards selfish (clonal) reproduction. To address this dilemma, mechanisms have evolved to enforce a mandate for gene sharing. In most metazoa, the functions of sex and reproduction are tightly entwined, presumably for the purpose of compelling the sharing of genes. In protists, the functions of sex (conjugation) and reproduction (amitosis) are separate. The mandate for gene sharing is enforced, instead, by a form of cellular senescence. Ciliates can reproduce clonally a few hundred times before they senesce and die. Conjugation resets their biological clock, restarting the cycle of clonal reproduction. The question how reproduction in metazoa came to be linked to sex has been explored in the past, but a fully satisfying account in terms of evolutionary ecology is lacking. The question how senescence in protozoa came to be linked to sex has not been addressed, and is the topic of the current study. I present herein two numerical simulations (IBMs) for the evolution of cellular senescence in ciliates. The results shed light not only on the evolution of senescence in higher life forms, but on more general questions concerning the plausibility of group selection.
- Open Access
- 16 November 2024
- Published by Qeios Ltd
Review of: "Computer Analysis of Stochastic Aging According to the Gompertz-Makeham Mortality Law"
The Gompertz function is an empirical fit to the probability of death as a function of age. In its usual application, parameters of the Gompertz function are chosen to match observations of a known species in a known environment. This MS proposes to...
- 16 November 2024
- Published by Qeios Ltd
Open AccessReview of: "Computer Analysis of Stochastic Aging According to the Gompertz-Makeham Mortality Law"
The Gompertz function is an empirical fit to the probability of death as a function of age. In its usual application, parameters of the Gompertz function are chosen to match observations of a known species in a known environment. This MS proposes to...
- Open Access
Origin of Cellular Senescence in Ciliates
Mixing and sharing of genes is essential for population diversity, which contributes to the resilience and, ultimately, the survival of animal and plant communities. However, sharing of genes is antithetical to individual fitness; hence gene mixing is threatened with extinction if selection rewards selfish (clonal) reproduction. To address this dilemma, mechanisms have evolved to enforce a mandate for gene sharing. In most metazoa, the functions of sex and reproduction are tightly entwined, presumably for the purpose of compelling the sharing of genes. In protists, the functions of sex (conjugation) and reproduction (amitosis) are separate. The mandate for gene sharing is enforced, instead, by a form of cellular senescence. Ciliates can reproduce clonally a few hundred times before they senesce and die. Conjugation resets their biological clock, restarting the cycle of clonal reproduction. The question how reproduction in metazoa came to be linked to sex has been explored in the past, but a fully satisfying account in terms of evolutionary ecology is lacking. The question how senescence in protozoa came to be linked to sex has not been addressed, and is the topic of the current study. I present herein two numerical simulations (IBMs) for the evolution of cellular senescence in ciliates. The results shed light not only on the evolution of senescence in higher life forms, but on more general questions concerning the plausibility of group selection.
Open AccessOrigin of Cellular Senescence in Ciliates
Mixing and sharing of genes is essential for population diversity, which contributes to the resilience and, ultimately, the survival of animal and plant communities. However, sharing of genes is antithetical to individual fitness; hence gene mixing is threatened with extinction if selection rewards selfish (clonal) reproduction. To address this dilemma, mechanisms have evolved to enforce a mandate for gene sharing. In most metazoa, the functions of sex and reproduction are tightly entwined, presumably for the purpose of compelling the sharing of genes. In protists, the functions of sex (conjugation) and reproduction (amitosis) are separate. The mandate for gene sharing is enforced, instead, by a form of cellular senescence. Ciliates can reproduce clonally a few hundred times before they senesce and die. Conjugation resets their biological clock, restarting the cycle of clonal reproduction. The question how reproduction in metazoa came to be linked to sex has been explored in the past, but a fully satisfying account in terms of evolutionary ecology is lacking. The question how senescence in protozoa came to be linked to sex has not been addressed, and is the topic of the current study. I present herein two numerical simulations (IBMs) for the evolution of cellular senescence in ciliates. The results shed light not only on the evolution of senescence in higher life forms, but on more general questions concerning the plausibility of group selection.
- 1 February 2024
- Published by Pleiades Publishing Ltd in Biochemistry (Moscow)
- Vol. 89 (2) , 356-366
Biological Clocks: Why We Need Them, Why We Cannot Trust Them, How They Might Be Improved
Late in life, the body is at war with itself. There is a program of self-destruction (phenoptosis) implemented via epigenetic and other changes. I refer to these as type (1) epigenetic changes. But the body retains a deep instinct for survival, and other epigenetic changes unfold in response to a perception of accumulated damage (type (2)). In the past decade, epigenetic clocks have promised to accelerate the search for anti-aging interventions by permitting prompt, reliable, and convenient measurement of their effects on lifespan without having to wait for trial results on mortality and morbidity. However, extant clocks do not distinguish between type (1) and type (2). Reversing type (1) changes extends lifespan, but reversing type (2) shortens lifespan. This is why all extant epigenetic clocks may be misleading. Separation of type (1) and type (2) epigenetic changes will lead to more reliable clock algorithms, but this cannot be done with statistics alone. New experiments are proposed. Epigenetic changes are the means by which the body implements phenoptosis, but they do not embody a clock mechanism, so they cannot be the body’s primary timekeeper. The timekeeping mechanism is not yet understood, though there are hints that it may be (partially) located in the hypothalamus. For the future, we expect that the most fundamental measurement of biological age will observe this clock directly, and the most profound anti-aging interventions will manipulate it.
- 1 February 2024
- Published by Pleiades Publishing Ltd in Biochemistry (Moscow)
- Vol. 89 (2) , 356-366
Biological Clocks: Why We Need Them, Why We Cannot Trust Them, How They Might Be Improved
Late in life, the body is at war with itself. There is a program of self-destruction (phenoptosis) implemented via epigenetic and other changes. I refer to these as type (1) epigenetic changes. But the body retains a deep instinct for survival, and other epigenetic changes unfold in response to a perception of accumulated damage (type (2)). In the past decade, epigenetic clocks have promised to accelerate the search for anti-aging interventions by permitting prompt, reliable, and convenient measurement of their effects on lifespan without having to wait for trial results on mortality and morbidity. However, extant clocks do not distinguish between type (1) and type (2). Reversing type (1) changes extends lifespan, but reversing type (2) shortens lifespan. This is why all extant epigenetic clocks may be misleading. Separation of type (1) and type (2) epigenetic changes will lead to more reliable clock algorithms, but this cannot be done with statistics alone. New experiments are proposed. Epigenetic changes are the means by which the body implements phenoptosis, but they do not embody a clock mechanism, so they cannot be the body’s primary timekeeper. The timekeeping mechanism is not yet understood, though there are hints that it may be (partially) located in the hypothalamus. For the future, we expect that the most fundamental measurement of biological age will observe this clock directly, and the most profound anti-aging interventions will manipulate it.
- Open Access
- 1 May 2023
- Published by Elsevier in Experimental Gerontology
- Vol. 177, 112182
How does the body know how old it is?
- 1 May 2023
- Published by Elsevier in Experimental Gerontology
- Vol. 177, 112182
Open AccessHow does the body know how old it is?
- Open Access
- 29 November 2021
- Published by Wiley
Improving CDC Data Practices Recommendations for Improving the United States Centers for Disease Control (CDC) Data Practices for Pneumonia, Influenza, and COVID-19 (v 1.1)
During the pandemic, millions of Americans have become acquainted with the CDC because its reports and the data it collects affect their day-today lives. But the methodology used and even some of the data collected by CDC remain opaque to the public and even to epidemiologists. In this paper, we highlight areas in which CDC methodology might be improved and where greater transparency could lead to broad collaboration. (1) "Excess" deaths are routinely reported, but not "years of life lost", an easily-computed and more granular datum that is important for public policy. (2) What counts as an "excess death"? The method for computing the number of excess deaths does not include error bars and we show a substantial range of estimates is possible. (3) Pneumonia and influenza death data on different CDC pages is grossly contradictory. (4) The methodology for computing influenza deaths is not described in sufficient detail that an outside analyst might pursue the source of the discrepancy. (5) Guidelines for filling out death certificates have changed during the COVID-19 pandemic, preventing the comparison of 2020-21 death profiles with any previous year. We conclude with a series of explicit recommendations for greater consistency and transparency, and ultimately to make CDC data more useful to the public and epidemiologists and other scientists.
- 29 November 2021
- Published by Wiley
Open AccessImproving CDC Data Practices Recommendations for Improving the United States Centers for Disease Control (CDC) Data Practices for Pneumonia, Influenza, and COVID-19 (v 1.1)
During the pandemic, millions of Americans have become acquainted with the CDC because its reports and the data it collects affect their day-today lives. But the methodology used and even some of the data collected by CDC remain opaque to the public and even to epidemiologists. In this paper, we highlight areas in which CDC methodology might be improved and where greater transparency could lead to broad collaboration. (1) "Excess" deaths are routinely reported, but not "years of life lost", an easily-computed and more granular datum that is important for public policy. (2) What counts as an "excess death"? The method for computing the number of excess deaths does not include error bars and we show a substantial range of estimates is possible. (3) Pneumonia and influenza death data on different CDC pages is grossly contradictory. (4) The methodology for computing influenza deaths is not described in sufficient detail that an outside analyst might pursue the source of the discrepancy. (5) Guidelines for filling out death certificates have changed during the COVID-19 pandemic, preventing the comparison of 2020-21 death profiles with any previous year. We conclude with a series of explicit recommendations for greater consistency and transparency, and ultimately to make CDC data more useful to the public and epidemiologists and other scientists.
- Open Access
- 19 July 2021
- Published by Wiley
Improving CDC Data Practices Recommendations for Improving the United States Centers for Disease Control (CDC) Data Practices for Pneumonia, Influenza, and COVID-19
During the pandemic, millions of Americans have become acquainted with the CDC because its reports and the data it collects affect their day-today lives. But the methodology used and even some of the data collected by CDC remain opaque to the public and to the community of academic epidemiology. In this paper, we highlight areas in which CDC methodology might be improved and where greater transparency might lead to broad collaboration. (1) "Excess" deaths are routinely reported, but not "years of life lost", an easily-computed datum that is important for public policy. (2) What counts as an "excess death"? The method for computing the number of excess deaths does not include error bars and we show a substantial range of estimates is possible. (3) Pneumonia and influenza death data on different CDC pages is grossly contradictory. (4) The methodology for computing influenza deaths is not described in sufficient detail that an outside analyst might pursue the source of the discrepancy. (5) Guidelines for filling out death certificates have changed during the COVID-19 pandemic, preventing the comparison of 2020-21 death profiles with any previous year. We conclude with a series of explicit recommendations for greater consistency and transparency, and ultimately to make CDC data more useful to outside epidemiologists.
- 19 July 2021
- Published by Wiley
Open AccessImproving CDC Data Practices Recommendations for Improving the United States Centers for Disease Control (CDC) Data Practices for Pneumonia, Influenza, and COVID-19
During the pandemic, millions of Americans have become acquainted with the CDC because its reports and the data it collects affect their day-today lives. But the methodology used and even some of the data collected by CDC remain opaque to the public and to the community of academic epidemiology. In this paper, we highlight areas in which CDC methodology might be improved and where greater transparency might lead to broad collaboration. (1) "Excess" deaths are routinely reported, but not "years of life lost", an easily-computed datum that is important for public policy. (2) What counts as an "excess death"? The method for computing the number of excess deaths does not include error bars and we show a substantial range of estimates is possible. (3) Pneumonia and influenza death data on different CDC pages is grossly contradictory. (4) The methodology for computing influenza deaths is not described in sufficient detail that an outside analyst might pursue the source of the discrepancy. (5) Guidelines for filling out death certificates have changed during the COVID-19 pandemic, preventing the comparison of 2020-21 death profiles with any previous year. We conclude with a series of explicit recommendations for greater consistency and transparency, and ultimately to make CDC data more useful to outside epidemiologists.
- 18 December 2019
- Published by Pleiades Publishing Ltd in Biochemistry (Moscow)
- Vol. 84 (12-13) , 1458-1468
What Is Antagonistic Pleiotropy?
Antagonistic Pleiotropy (AP) is today the best-accepted theory for the evolutionary origin of aging. According to AP theory, aging is a side effect of genes that are selected for their contribution...
- 18 December 2019
- Published by Pleiades Publishing Ltd in Biochemistry (Moscow)
- Vol. 84 (12-13) , 1458-1468
What Is Antagonistic Pleiotropy?
Antagonistic Pleiotropy (AP) is today the best-accepted theory for the evolutionary origin of aging. According to AP theory, aging is a side effect of genes that are selected for their contribution...